This research area aims at developing capabilities for viral genome sequencing of all positive patients to follow mutations and enable tracing of infection spread. The large-scale genome sequencing capability will also contribute to establishing a database of genome variation in collaboration with similar sequencing efforts such as the UK COVID-19 Sequencing Consortium.
This area consists of 4 individual projects, funded a total of 1,7 MSEK. Led by researchers at Uppsala University, Karolinska Institutet, Stockholm University.
Coordinator: Alice Sollazzo, Uppsala University
Scientific lead: Ulf Gyllensten, Uppsala University
COVseq – Developing COVseq for mass-scale SARS-CoV-2 sequencing
Nicola Crosetto, Karolinska Institutet
A community resource for SARS-CoV-2 structure, interactome and evolution
Arne Elofsson, Stockholm University
Rapid cDNA and direct RNA sequencing of SARS-CoV-2 using Oxford Nanopore
Lars Feuk, Uppsala University
Analysis of essential genes and validity as drug targets
Tomas Nyman, Karolinska Institutet
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.